UNIVERSAL HEALTH SERVICES INC
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
5 Revealing Analyst Questions From Universal Health Services’s Q2 Earnings Call
Universal Health Services delivered an 8.3% year-over-year increase in revenue for Q2 2026, surpassing Wall Street’s revenue expectations. Management pointed to a rebound in both acute care and behavioral health volumes, supported by investments in expanding capacity and disciplined expense management. President and CEO Marc D. Miller highlighted the opening of new hospital beds and the Alan B. Miller Medical Center in Florida as bolstering demand response, and noted that professional and genera
RBC Capital Maintains Sector Perform on Universal Health Services, Lowers Price Target to $183
RBC Capital analyst Ben Hendrix maintains Universal Health Services (NYSE:UHS) with a Sector Perform and lowers the price target from $190 to $183.
Goldman Sachs Maintains Neutral on Universal Health Services, Lowers Price Target to $190
Goldman Sachs analyst Scott Fidel maintains Universal Health Services (NYSE:UHS) with a Neutral and lowers the price target from $242 to $190.
Morgan Stanley Maintains Equal-Weight on Universal Health Services, Lowers Price Target to $191
Morgan Stanley analyst Craig Hettenbach maintains Universal Health Services (NYSE:UHS) with a Equal-Weight and lowers the price target from $212 to $191.
Universal Health Services: Valuations Look Attractive After A Meaningful Correction
Initiating Buy on Universal Health Services (UHS): behavioral health growth, strong cash flows, low leverage, and a big EV/EBITDA discountâread now.
These Analysts Slash Their Forecasts On Universal Health Services Following Q2 Earnings
Universal Health Services (NYSE: UHS) reported strong Q2 results and lowered FY26 EPS guidance. Share price up 0.6%. Analysts adjust price targets.
Guggenheim Maintains Buy on Universal Health Services, Lowers Price Target to $189
Guggenheim analyst Jason Cassorla maintains Universal Health Services (NYSE:UHS) with a Buy and lowers the price target from $195 to $189.
Cantor Fitzgerald Reiterates Neutral on Universal Health Services, Maintains $194 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Universal Health Services (NYSE:UHS) with a Neutral and maintains $194 price target.
Baird Maintains Neutral on Universal Health Services, Lowers Price Target to $166
Baird analyst Michael Ha maintains Universal Health Services (NYSE:UHS) with a Neutral and lowers the price target from $204 to $166.
UHS Q2 Deep Dive: Acute Care Growth and Outpatient Initiatives Shape Outlook
Hospital management company Universal Health Services (NYSE:UHS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.3% year on year to $4.64 billion. The company’s full-year revenue guidance of $18.63 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $5.98 per share was in line with analysts’ consensus estimates.
Congressional Trades in $UHS
View full $UHS trading history →Insider Trades (Form 4)
MILLER ALAN B
Key People
MILLER ALAN B
Executive Chairman
Political Giving
$23,000 given to 11 candidates across 12 disclosed contributions (FEC Schedule A).
Dave McCormick
David Kustoff
Shelley Moore Capito
Adam Smith
Thom Tillis
Katherine M. Clark
Markwayne Mullin
Carol Devine Miller
Terri A. Sewell
Charles J. "Chuck" Fleischmann
Bill Hagerty
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro